(NHI) National Health Investors - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US63633D1046

NHI EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of NHI over the last 5 years for every Quarter.

NHI Revenue

This chart shows the Revenue of NHI over the last 5 years for every Quarter.

NHI: Senior, Housing, Healthcare, Financing, Investments

National Health Investors Inc (NYSE: NHI) is a real estate investment trust that has been operating since 1991, focusing on senior housing and medical investments through various financial structures such as sale-leasebacks, joint ventures, and mortgage financing. The companys diverse portfolio includes independent living, assisted living, and memory care communities, as well as skilled nursing facilities and specialty hospitals, catering to the growing demand for senior care services.

With a strong presence in the healthcare REIT sector, NHI has established itself as a significant player, providing need-driven and discretionary senior housing and medical investments. The companys business model is designed to generate stable income through rental payments, interest on loans, and other investment returns, making it an attractive option for investors seeking exposure to the healthcare real estate market.

Analyzing the current market data, NHIs stock price is currently at $71.84, slightly below its short-term moving averages (SMA20: $72.93, SMA50: $73.81), indicating a potential buying opportunity. The stocks ATR of 1.51 represents a 2.10% daily price range, suggesting moderate volatility. Considering the 52-week high and low prices ($82.14 and $61.42, respectively), the stock is currently trading near the lower end of its recent price range.

Combining the technical and fundamental data, a forecast for NHI can be derived. With a market capitalization of $3.385 billion and a forward P/E ratio of 12.84, the stock appears to be undervalued relative to its earnings potential. Additionally, the companys return on equity (RoE) of 10.72% indicates a stable and profitable business model. Based on these factors, a potential price target for NHI could be around $80-$85, representing a 11-18% upside from current levels, driven by the companys strong fundamentals and the growing demand for senior housing and medical investments.

As the senior population continues to grow, NHI is well-positioned to benefit from this trend, with its diversified portfolio and flexible business model. Investors seeking exposure to the healthcare REIT sector may consider NHI as a viable option, given its stable income generation and potential for long-term growth.

Additional Sources for NHI Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

NHI Stock Overview

Market Cap in USD 3,312m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 1991-10-09

NHI Stock Ratings

Growth Rating 35.9
Fundamental 37.1
Dividend Rating 45.8
Rel. Strength -1
Analysts 3.88 of 5
Fair Price Momentum 72.44 USD
Fair Price DCF 96.18 USD

NHI Dividends

Dividend Yield 12m 6.28%
Yield on Cost 5y 10.29%
Annual Growth 5y -3.99%
Payout Consistency 93.8%
Payout Ratio 119.3%

NHI Growth Ratios

Growth Correlation 3m -32.4%
Growth Correlation 12m -1.5%
Growth Correlation 5y 55.6%
CAGR 5y 10.09%
CAGR/Max DD 5y 0.32
Sharpe Ratio 12m 1.00
Alpha 5.29
Beta 0.370
Volatility 22.53%
Current Volume 588.3k
Average Volume 20d 285k
What is the price of NHI shares?
As of June 21, 2025, the stock is trading at USD 70.77 with a total of 588,310 shares traded.
Over the past week, the price has changed by -0.23%, over one month by -5.30%, over three months by -4.17% and over the past year by +11.65%.
Is National Health Investors a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, National Health Investors (NYSE:NHI) is currently (June 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 37.10 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NHI is around 72.44 USD . This means that NHI is currently overvalued and has a potential downside of 2.36%.
Is NHI a buy, sell or hold?
National Health Investors has received a consensus analysts rating of 3.88. Therefor, it is recommend to buy NHI.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for NHI share price target?
According to our own proprietary Forecast Model, NHI National Health Investors will be worth about 78.2 in June 2026. The stock is currently trading at 70.77. This means that the stock has a potential upside of +10.54%.
Issuer Target Up/Down from current
Wallstreet Target Price 80.9 14.3%
Analysts Target Price 80.7 14%
ValueRay Target Price 78.2 10.5%